Bio-Rad Laboratories ( (BIO) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bio-Rad Laboratories’ stock movement is influenced by Wells Fargo’s decision to lower the company’s price target. This adjustment comes in light of updated financial outlooks and macroeconomic conditions impacting growth projections. Despite reporting a strong Q2 revenue of $651.6 million, surpassing expectations due to effective execution and expense management, the stock faces pressure. Key developments include the acquisition of Stilla Technologies and the expansion of their digital PCR offerings.
More about Bio-Rad Laboratories
YTD Price Performance: -23.33%
Average Trading Volume: 354,402
Technical Sentiment Signal: Sell
Current Market Cap: $6.88B
For further insights into BIO stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.